A Parallel Phase 2 Study of Glesatinib, Sitravatinib or

Project: Research project

Description

A Parallel Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Advanced or Metastatic Non-Small Cell Lung Cancer
StatusActive
Effective start/end date1/1/1712/31/20

Funding

  • MIRATI THERAPEUTICS, INC.

Fingerprint

Non-Small Cell Lung Carcinoma
nivolumab
mocetinostat